Ttk protein kinase gene for diagnosing and treating non-small cell lung cancers
CA 2500151 A1 · Owner: Nakatsuru, Shuichi · Inventors: Nakamura, Yusuke; Daigo, Yataro; Nakatsuru, Shuichi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are methods for detecting non-small cell lung cancer using differentially expressed genes. Furthermore novel human genes whose , expression is elevated in non-small cell lung cancer compared to no-cancerous tissues are provided. Also disclosed are methods of identifying compounds for treating and preventing non-small cell lung cancer.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 22, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 22, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 22, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.